Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
14 09 2022
Historique:
received: 01 11 2021
revised: 30 12 2021
accepted: 23 01 2022
pubmed: 9 6 2022
medline: 17 9 2022
entrez: 8 6 2022
Statut: ppublish

Résumé

While neuropathological examinations in patients who died from COVID-19 revealed inflammatory changes in cerebral white matter, cerebral MRI frequently fails to detect abnormalities even in the presence of neurological symptoms. Application of multi-compartment diffusion microstructure imaging (DMI), that detects even small volume shifts between the compartments (intra-axonal, extra-axonal and free water/CSF) of a white matter model, is a promising approach to overcome this discrepancy. In this monocentric prospective study, a cohort of 20 COVID-19 inpatients (57.3 ± 17.1 years) with neurological symptoms (e.g. delirium, cranial nerve palsies) and cognitive impairments measured by the Montreal Cognitive Assessment (MoCA test; 22.4 ± 4.9; 70% below the cut-off value <26/30 points) underwent DMI in the subacute stage of the disease (29.3 ± 14.8 days after positive PCR). A comparison of whole-brain white matter DMI parameters with a matched healthy control group (n = 35) revealed a volume shift from the intra- and extra-axonal space into the free water fraction (V-CSF). This widespread COVID-related V-CSF increase affected the entire supratentorial white matter with maxima in frontal and parietal regions. Streamline-wise comparisons between COVID-19 patients and controls further revealed a network of most affected white matter fibres connecting widespread cortical regions in all cerebral lobes. The magnitude of these white matter changes (V-CSF) was associated with cognitive impairment measured by the MoCA test (r = -0.64, P = 0.006) but not with olfactory performance (r = 0.29, P = 0.12). Furthermore, a non-significant trend for an association between V-CSF and interleukin-6 emerged (r = 0.48, P = 0.068), a prominent marker of the COVID-19 related inflammatory response. In 14/20 patients who also received cerebral 18F-FDG PET, V-CSF increase was associated with the expression of the previously defined COVID-19-related metabolic spatial covariance pattern (r = 0.57; P = 0.039). In addition, the frontoparietal-dominant pattern of neocortical glucose hypometabolism matched well to the frontal and parietal focus of V-CSF increase. In summary, DMI in subacute COVID-19 patients revealed widespread volume shifts compatible with vasogenic oedema, affecting various supratentorial white matter tracts. These changes were associated with cognitive impairment and COVID-19 related changes in 18F-FDG PET imaging.

Identifiants

pubmed: 35675908
pii: 6604299
doi: 10.1093/brain/awac045
pmc: PMC9214163
doi:

Substances chimiques

Water 059QF0KO0R
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3203-3213

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Neurobiol Aging. 2021 Mar;99:28-43
pubmed: 33422892
Magn Reson Imaging Clin N Am. 2021 Feb;29(1):67-75
pubmed: 33237016
Nat Rev Neurosci. 2017 Jun;18(6):375-384
pubmed: 28446786
Neurology. 2020 Oct 6;95(14):e2016-e2027
pubmed: 32546654
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neuroimage. 2011 Jan 15;54(2):955-62
pubmed: 20854913
Mov Disord. 2021 May;36(5):1126-1136
pubmed: 33470460
J Neurol Sci. 2021 Aug 15;427:117517
pubmed: 34090021
Eur J Neurol. 2019 Aug;26(8):1068-1074
pubmed: 30761708
Seizure. 2018 Jan;54:11-18
pubmed: 29172093
Brain Commun. 2022 Jan 19;4(1):fcab295
pubmed: 35128398
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Front Aging Neurosci. 2021 Jun 15;13:682109
pubmed: 34211389
Neurology. 2020 Sep 22;95(12):e1754-e1759
pubmed: 32546655
AJNR Am J Neuroradiol. 2020 Dec;41(12):2199-2203
pubmed: 32883670
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
Sci Adv. 2020 Aug 07;6(32):eaaz6892
pubmed: 32821816
EClinicalMedicine. 2020 Aug;25:100484
pubmed: 32838240
Viruses. 2019 Dec 20;12(1):
pubmed: 31861926
Nat Aging. 2022 Dec;2(12):1130-1137
pubmed: 37118539
J Cereb Blood Flow Metab. 2021 Jul;41(7):1563-1578
pubmed: 33183133
Immunity. 2021 Jul 13;54(7):1594-1610.e11
pubmed: 34174183
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Neuroimage. 2016 Nov 15;142:394-406
pubmed: 27523449
Neuroimage. 2017 Feb 15;147:964-975
pubmed: 27746388
Eur J Radiol. 2020 Dec;133:109393
pubmed: 33161199
J Neurosci Methods. 2020 Dec 1;346:108908
pubmed: 32814118
J Nucl Med. 2021 Jul 1;62(7):910-915
pubmed: 33789937
Transl Psychiatry. 2021 May 21;11(1):307
pubmed: 34021116
Neuroimage. 2019 Jan 15;185:534-544
pubmed: 30326293
J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):404-411
pubmed: 30361295
Neuroimage. 2015 Jan 15;105:32-44
pubmed: 25462697
Int J Mol Sci. 2021 Jul 13;22(14):
pubmed: 34299111
Indian J Clin Biochem. 2021 Oct;36(4):440-450
pubmed: 34177139
Brain. 2021 May 7;144(4):1263-1276
pubmed: 33822001
Sci Transl Med. 2021 Jul 14;13(602):
pubmed: 34131052
J Magn Reson. 2018 Aug;293:134-144
pubmed: 30012279
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
Radiology. 2020 Nov;297(2):E242-E251
pubmed: 32544034
Rhinology. 1996 Dec;34(4):222-6
pubmed: 9050101
Neuroimage. 2012 Jul 16;61(4):1000-16
pubmed: 22484410
J Neurol. 2020 Dec;267(12):3476-3478
pubmed: 32647900
J Vis Exp. 2013 Jun 26;(76):
pubmed: 23851955
Intensive Care Med. 2021 Jan;47(1):116-118
pubmed: 33034688
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2543-2557
pubmed: 33452633
Brain. 2021 Oct 22;144(9):2696-2708
pubmed: 33856027
Sci Adv. 2020 Jul 31;6(31):
pubmed: 32937591
Neuroimage Clin. 2017 May 17;15:333-342
pubmed: 28560158
Cereb Cortex. 2015 Jun;25(6):1477-89
pubmed: 24343892
J Clin Invest. 2021 Apr 15;131(8):
pubmed: 33630760
Magn Reson Med. 2016 Nov;76(5):1574-1581
pubmed: 26745823
Stroke. 2012 Jun;43(6):1700-5
pubmed: 22492515
Neuroimage. 2008 Jan 1;39(1):336-47
pubmed: 17931890

Auteurs

Alexander Rau (A)

Department of Neuroradiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nils Schroeter (N)

Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ganna Blazhenets (G)

Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Andrea Dressing (A)

Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Freiburg Brain Imaging Center, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Lea I Walter (LI)

Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Elias Kellner (E)

Department of Medical Physics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Tobias Bormann (T)

Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Freiburg Brain Imaging Center, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Hansjörg Mast (H)

Department of Neuroradiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Dirk Wagner (D)

Department of Internal Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Horst Urbach (H)

Department of Neuroradiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Cornelius Weiller (C)

Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Freiburg Brain Imaging Center, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Philipp T Meyer (PT)

Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Marco Reisert (M)

Department of Medical Physics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Stereotactic and Functional Neurosurgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Jonas A Hosp (JA)

Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH